CEI Van Outreach Screening Study

Completed

Conditions studied: Glaucoma, Macular Disease, Keratoconus

In brief

The primary goal of the trial is to show that optical coherence tomography (OCT) technology can be used to effectively screen for diseases of the eye including glaucoma, macular diseases and keratoconus. Glaucoma is a disease that causes permanent vision loss and is usually accompanied by increased eye pressure. Macular diseases affect sharp, central vision. Keratoconus is a disease that affects the cornea (clear surface covering the colored part of the eye).

Key facts

Study ID

NCT01510392

Run by

Oregon Health and Science University

People needed

118

Starts

2012-01-01

Expected to finish

2017-02-02

Last updated by the study team

2018-04-12

Who can join

Age: 18 and older, up to 89. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Participant undergoing a screening examination at the Casey Eye Institute Outreach Van.
• Participants must be between the ages of 18 and 89 years old.

You may not qualify if…

• Inability to give informed consent.
• Inability to maintain stable fixation for OCT imaging

Where it is running

• Casey Eye Institute Outreach Screening Van — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.